131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Clinical trial NCT04743661 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04743661
- Sponsor
- Pediatric Brain Tumor Consortium
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-04
- Primary completion
- 2026-04-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.